Megan Elizabeth Bowles Clowse, MD

Associate Professor of Medicine
Campus mail Baker House 07, Duke South, Trent Drive, Durham, NC 27710
Phone (919) 681-2045
Email address megan.clowse@duke.edu

Dr. Megan Clowse is an Associate Professor of Medicine, Rheumatology and Immunology.  Her clinical research focuses on the management of rheumatologic diseases in pregnancy. Her current studies include identification of causes for the high rate of infertility among women with rheumatoid arthritis and understanding how psoriatic arthritis impacts pregnancy.

She has conducted studies on vasculitis and ovarian function and pregnancy. She is the Director of the Vasculitis-Pregnancy Registry, an online pregnancy registry for women with these rare conditions.  Additionally, she has collected prospective pregnancies in women with rheumatic disease in the Duke Autoimmunity in Pregnancy Registry that includes clinical data, pregnancy outcomes, and a large sample repository.

In Their Words

Education and Training

  • Fellow in Rheumatology, Medicine, Johns Hopkins University, 2002 - 2005
  • Medical Residetn, Medicine, Johns Hopkins University, 1999 - 2002
  • M.D., Vanderbilt University, 1999
  • M.P.H., University of California at Los Angeles, 1994

Publications

Eudy, AM, Petri, M, Fischer-Betz, R, Mokbel, A, Nalli, C, Andreoli, L, Tincani, A, Molad, Y, Balevic, S, and Clowse, MEB. "Hydroxychloroquine in Lupus Pregnancy: A Meta-Analysis of Individual Participant Data.": WILEY, October 1, 2017.

Scholars@Duke

Haroun, T, Eudy, AM, Jayasundara, M, Nowell, WB, Curtis, JR, White, CW, Crow-Hercher, R, Ginsberg, SD, and Clowse, MEB. "Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation.": WILEY, October 1, 2017.

Scholars@Duke

Haroun, T, Eudy, AM, Jayasundara, M, Nowell, WB, Curtis, JR, White, CW, Crow-Hercher, R, Ginsberg, SD, and Clowse, MEB. "Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation.": WILEY, October 1, 2017.

Scholars@Duke

Jayasundara, M, Eudy, AM, Haroun, T, Nowell, WB, Curtis, JR, Crow-Hercher, R, White, CW, Ginsberg, SD, and Clowse, MEB. "Answering Reproductive Health Questions That Your Patients Want to Know: Impediments to Family Building and Risks of Contraception.": WILEY, October 1, 2017.

Scholars@Duke

Jayasundara, M, Eudy, AM, Haroun, T, Nowell, WB, Curtis, JR, Crow-Hercher, R, White, CW, Ginsberg, SD, and Clowse, MEB. "Answering Reproductive Health Questions That Your Patients Want to Know: Impediments to Family Building and Risks of Contraception.": WILEY, October 1, 2017.

Scholars@Duke

Clowse, MEB, Scheuerle, AE, Chambers, CD, Afzali, A, Kimball, A, Cush, JJ, Cooney, M, Shaughnessy, L, Vanderkelen, M, and Forger, F. "Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database.": WILEY, October 1, 2017.

Scholars@Duke

Clowse, MEB, Scheuerle, AE, Chambers, CD, Afzali, A, Kimball, A, Cush, JJ, Cooney, M, Shaughnessy, L, Vanderkelen, M, and Forger, F. "Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database.": WILEY, October 1, 2017.

Scholars@Duke

Balevic, S, Cohen-Wolkowiez, M, Eudy, AM, Schanberg, LE, and Clowse, MEB. "Hydroxychloroquine Level Decreases throughout Pregnancy: Implications for Maternal and Neonatal Outcomes." October 2017.

Scholars@Duke

Clowse, MEB, Forger, F, Hwang, C, Thorp, J, Dolhain, RJEM, van Tubergen, A, Teil, M, Toublanc, N, and Hale, T. "Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study." Annual Meeting of the American-Academy-of-Dermatology. Orlando, FL. March 3, 2017 - March 7, 2017.: MOSBY-ELSEVIER, June 1, 2017.

Scholars@Duke

Clowse, MEB, Forger, F, Hwang, C, Thorp, J, Dolhain, RJEM, van Tubergen, A, Teil, M, Toublanc, N, and Hale, T. "Evaluating transfer of certolizumab pegol into breast milk: Results from a prospective, postmarketing, multicenter pharmacokinetic study." Annual Meeting of the American-Academy-of-Dermatology. Orlando, FL. March 3, 2017 - March 7, 2017.: MOSBY-ELSEVIER, June 1, 2017.

Scholars@Duke

Pages